The placees handed over $3 million . You don't do that if you think the co has something going for it . Read the last lines .
“This capital raising places the Company in a stronger financial position with opportunities to accelerate R&D commercial activities, particularly in the area of controlled slow release drug delivery technologies,” said Dr Roger Brimblecombe, Executive Chairman and CEO of pSivida Limited. “I am particularly pleased by the reappointment of Dr Aston to the pSivida Board as we move towards significant commercial opportunities in the near term.”
The AFR stated last week that a big pharma deal was on the cards . I don't know .
PSD Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
